05:58 PM EDT, 08/14/2025 (MT Newswires) -- Thomas Andrew Rowland, Senior Vice President, and Head, Established Brands, on August 12, 2025, sold 4,975 shares in Ani Pharmaceuticals ( ANIP ) for $426,407. Following the Form 4 filing with the SEC, Rowland has control over a total of 40,794 common shares of the company, with 40,794 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1023024/000150749625000007/xslF345X05/wk-form4_1755208382.xml